Center for Scientific Review; Notice of Closed Meetings, 73118-73119 [2016-25587]
Download as PDF
73118
Federal Register / Vol. 81, No. 205 / Monday, October 24, 2016 / Notices
technology to minimize the information
collection burden.
Amy McNulty,
Deputy Director, Division of the Executive
Secretariat.
[FR Doc. 2016–25618 Filed 10–21–16; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Advisory Committee on
Blood and Tissue Safety and
Availability
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services is hereby giving notice that the
Advisory Committee on Blood and
Tissue Safety and Availability
(ACBTSA) will hold a meeting. The
meeting will be open to the public.
DATES: The meeting will take place
Monday November 28, 2016, from 9:30
a.m.–4:00 p.m. and Tuesday November
29, 2016, from 8:30 a.m.–4:00 p.m.
ADDRESSES: Veterans’ Health
Administration National Conference
Center, 2011 Crystal Drive, 1st floor
Conference Center, Crystal City, VA
22202.
FOR FURTHER INFORMATION CONTACT: Mr.
James Berger, Designated Federal Officer
for the ACBTSA, Senior Advisor for
Blood and Tissue Policy, Office of the
Assistant Secretary for Health,
Department of Health and Human
Services, Mary E. Switzer Building, 330
C Street SW., Suite L100, Washington,
DC 20024. Phone: (202)-795–7697; Fax:
(202)-691–2102; Email: ACBTSA@
hhs.gov.
SUPPLEMENTARY INFORMATION: The
ACBTSA provides advice to the
Secretary through the Assistant
Secretary for Health. The Committee
advises on a range of policy issues to
include: (1) Identification of public
health issues through surveillance of
blood and tissue safety issues with
national biovigilance data tools; (2)
identification of public health issues
that affect availability of blood, blood
products, and tissues; (3) broad public
health, ethical, and legal issues related
to the safety of blood, blood products,
and tissues; (4) the impact of various
economic factors (e.g., product cost and
supply) on safety and availability of
blood, blood products, and tissues; (5)
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:42 Oct 21, 2016
Jkt 241001
risk communications related to blood
transfusion and tissue transplantation;
and (6) identification of infectious
disease transmission issues for blood,
organs, blood stem cells and tissues.
The Committee has met regularly since
its establishment in 1997.
In December 2013, the Committee
made recommendations regarding the
blood system. At that time, the
Committee expressed concern about the
ongoing reductions in blood use, the
number of large scale consolidations
occurring, the cost recovery issues for
blood centers, and the potential effects
on safety and innovation due to
instability. In November 2015, the
Committee made recommendations
again, reaffirming the December 2013
recommendations, highlighting the
worsening conditions, and suggesting
potential initiatives to address the
issues in the blood system. Past
recommendations made by the ACBTSA
may be viewed at https://www.hhs.gov/
ohaidp/initiatives/blood-tissue-safety/
advisory-committee/.
The Committee will meet on
November 28–29, 2016 to hear the
findings from the HHS sponsored RAND
study, ‘‘Toward a Sustainable Blood
Supply in the United States: An
Analysis of the Current System and
Alternatives for the Future.’’ The
ACBTSA Subcommittee on Blood
System Sustainability will present their
response to the study, and the full
Committee will discuss and develop
appropriate recommendations for HHS
consideration. Additional topics that are
pertinent to the mission of the
Committee may be added to the agenda.
The public will have an opportunity
to present their views to the Committee
during public comment sessions
scheduled for both days of the meeting.
Comments will be limited to five
minutes per speaker and must be
pertinent to the discussion. Preregistration is required for participation
in the public comment session. Any
member of the public who would like to
participate in this session is required to
submit their name, email, and comment
summary prior to close of business on
November 17, 2016. If it is not possible
to provide 30 copies of the material to
be distributed at the meeting, then
individuals are requested to provide a
minimum of one (1) copy of the
document(s) to be distributed prior to
the close of business on November 17,
2016. It is also requested that any
member of the public who wishes to
provide comments to the Committee
utilizing electronic data projection
submit the necessary material to the
Designated Federal Officer prior to the
close of business on November 17, 2016.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Dated: October 18, 2016.
James J. Berger,
Senior Advisor for Blood and Tissue Policy.
[FR Doc. 2016–25650 Filed 10–21–16; 8:45 am]
BILLING CODE 4150–41–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Health Services Organization and
Delivery.
Date: November 3, 2016.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Peter J Kozel, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
Bethesda, MD 20892, 301–435–1116, kozelp@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 14–
260: Health Promotion and Disease
Prevention among Native American
Populations.
Date: November 4, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Martha L Hare, RN, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3154,
MSC 7770, Bethesda, MD 20892, (301) 451–
8504, harem@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
E:\FR\FM\24OCN1.SGM
24OCN1
Federal Register / Vol. 81, No. 205 / Monday, October 24, 2016 / Notices
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Nursing and Related Clinical
Sciences.
Date: November 7, 2016.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Peter J Kozel, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
Bethesda, MD 20892, 301–435–1116, kozelp@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 18, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–25587 Filed 10–21–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: October 18, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy
National Institutes of Health
sradovich on DSK3GMQ082PROD with NOTICES
National Cancer Institute; Notice of
Meeting
[FR Doc. 2016–25588 Filed 10–21–16; 8:45 am]
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Frederick National Laboratory Advisory
Committee to the National Cancer
Institute.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
will also be videocast and can be
accessed from the NIH Videocasting and
Podcasting Web site (https://
videocast.nih.gov/).
Name of Committee: Frederick National
Laboratory Advisory Committee to the
National Cancer Institute.
Date: November 16, 2016.
Time: 1:00 p.m. to 5:30 p.m.
Agenda: Ongoing and new activities at the
Frederick National Laboratory for Cancer
Research.
VerDate Sep<11>2014
17:42 Oct 21, 2016
Jkt 241001
Place: National Cancer Institute Advanced
Technology Research Facility (ATRF) 8560
Progress Drive Auditorium Room E1600
Frederick, MD 21702.
Contact Person: Peter L. Wirth, Ph.D.
Executive Secretary National Cancer Institute
National Institutes of Health 9609 Medical
Center Drive Room 7W–514 Bethesda, MD
20892 240–276–6434 wirthp@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NCI’s Advanced
Technology Research Facility (ATRF) has
instituted stringent procedures for entrance
into the ATRF building. Visitors will be
asked to show one form of identification (for
example, a government-issued photo ID,
driver’s license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/fac/
facmeetings.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
73119
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
The Influence of Drug Abuse on HIV
Prevention, Treatment and Progression.
Date: November 16–17, 2016.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Shalanda A Bynum, Ph.D.,
M.P.H., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
Bethesda, MD 20892, 301–755–4355,
bynumsa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA R15
Grant Applications.
Date: November 17, 2016.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Michael M. Sveda, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2204,
MSC 7890, Bethesda, MD 20892, 301–435–
3565, svedam@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group;
NeuroAIDS and other End-Organ Diseases
Study Section.
Date: November 18, 2016.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Nikko San Francisco, 222
Mason Street, San Francisco, CA 94102.
Contact Person: Eduardo A Montalvo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7852, Bethesda, MD 20892, (301) 435–
1168, montalve@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Dermatology, Rheumatology and
Inflammation.
Date: November 18, 2016.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Rajiv Kumar, Ph.D., Chief,
MOSS IRG, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4216, MSC 7802, Bethesda, MD
20892, 301–435–1212, kumarra@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Infectious
Diseases, Reproductive Health, Asthma and
Pulmonary Conditions: Small Grant
Mechanisms.
Date: November 18, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
E:\FR\FM\24OCN1.SGM
24OCN1
Agencies
[Federal Register Volume 81, Number 205 (Monday, October 24, 2016)]
[Notices]
[Pages 73118-73119]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-25587]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Health Services Organization and Delivery.
Date: November 3, 2016.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Peter J Kozel, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3139, Bethesda, MD 20892, 301-435-1116,
kozelp@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR 14-260: Health Promotion and Disease Prevention among
Native American Populations.
Date: November 4, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Martha L Hare, RN, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3154, MSC 7770, Bethesda, MD
20892, (301) 451-8504, harem@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing
[[Page 73119]]
limitations imposed by the review and funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Nursing and Related Clinical Sciences.
Date: November 7, 2016.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Peter J Kozel, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3139, Bethesda, MD 20892, 301-435-1116,
kozelp@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 18, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-25587 Filed 10-21-16; 8:45 am]
BILLING CODE 4140-01-P